Similar articles for PMID: 24434288

Year	Number of Results
1983	1
2005	4
2007	6
2008	8
2009	7
2010	8
2011	4
2012	12
2013	13
2014	13
2015	10
2016	4
2017	4
2018	1
2019	1
2020	3
2021	3
2022	1
2023	1
2024	0

1

Fowler AM. Fowler AM. J Nucl Med. 2014 Feb;55(2):177-80. doi: 10.2967/jnumed.113.126102. Epub 2014 Jan 16. J Nucl Med. 2014. PMID: 24434288 Free article. Review.

2

Whole-body MR or PET-CT?

Schmidt GP. Schmidt GP. Eur J Radiol. 2012 Sep;81 Suppl 1:S142-3. doi: 10.1016/S0720-048X(12)70059-1. Eur J Radiol. 2012. PMID: 23083566 No abstract available.

3

Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer.

Dirisamer A, Halpern BS, Flöry D, Wolf F, Beheshti M, Mayerhoefer ME, Langsteger W. Dirisamer A, et al. Eur J Radiol. 2010 Feb;73(2):294-9. doi: 10.1016/j.ejrad.2008.10.031. Epub 2009 Feb 1. Eur J Radiol. 2010. PMID: 19181468

4

Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.

Sakurai Y, Kawai H, Iwano S, Ito S, Ogawa H, Naganawa S. Sakurai Y, et al. J Med Imaging Radiat Oncol. 2013 Jun;57(3):297-305. doi: 10.1111/1754-9485.12020. Epub 2012 Dec 28. J Med Imaging Radiat Oncol. 2013. PMID: 23721138 Clinical Trial.

5

Integrated whole-body PET/MR hybrid imaging: clinical experience.

Quick HH, von Gall C, Zeilinger M, Wiesmüller M, Braun H, Ziegler S, Kuwert T, Uder M, Dörfler A, Kalender WA, Lell M. Quick HH, et al. Invest Radiol. 2013 May;48(5):280-9. doi: 10.1097/RLI.0b013e3182845a08. Invest Radiol. 2013. PMID: 23442775

6

Recurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkers.

Gaeta CM, Vercher-Conejero JL, Sher AC, Kohan A, Rubbert C, Avril N. Gaeta CM, et al. Q J Nucl Med Mol Imaging. 2013 Dec;57(4):352-66. Q J Nucl Med Mol Imaging. 2013. PMID: 24322792 Free article. Review.

7

MRI and PET/CT of patients with bone metastases from breast carcinoma.

Grankvist J, Fisker R, Iyer V, Fründ ET, Simonsen C, Christensen T, Stenbygaard L, Ewertz M, Larsson EM. Grankvist J, et al. Eur J Radiol. 2012 Jan;81(1):e13-8. doi: 10.1016/j.ejrad.2010.10.024. Epub 2011 Jan 12. Eur J Radiol. 2012. PMID: 21227614

8

Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.

Schmidt GP, Kramer H, Reiser MF, Glaser C. Schmidt GP, et al. Top Magn Reson Imaging. 2007 Jun;18(3):193-202. doi: 10.1097/RMR.0b013e318093e6bo. Top Magn Reson Imaging. 2007. PMID: 17762383 Review.

9

Prone breast dual-time-point PET/CT compared with MRI for determining breast cancer.

Maguire GQ Jr, Noz ME, Ponzo F. Maguire GQ Jr, et al. AJR Am J Roentgenol. 2009 Jul;193(1):W77; author reply W78. doi: 10.2214/AJR.08.2243. AJR Am J Roentgenol. 2009. PMID: 19542389 No abstract available.

10

PET/CT for the staging and follow-up of patients with malignancies.

Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G. Poeppel TD, et al. Eur J Radiol. 2009 Jun;70(3):382-92. doi: 10.1016/j.ejrad.2009.03.051. Epub 2009 Apr 29. Eur J Radiol. 2009. PMID: 19406595 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

89 results

Results by year